(VIANEWS) - The Market ended the session with BIOSENIC (BIOS.BR) rising 9.06% to €0.14 on Thursday while BEL 20 jumped 0.62% to €3,652.55.
About BIOSENIC
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Volatility
BIOSENIC's last week, last month's, and last quarter's current intraday variation average was a negative 4.78%, a negative 1.77%, and a positive 6.31%.
BIOSENIC's highest amplitude of average volatility was 4.78% (last week), 6.15% (last month), and 6.31% (last quarter).
More news about BIOSENIC (BIOS.BR).